Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study
Surveillance Des données De l'Autosurveillance glycémique Via Internet Et Le réseau téléphonique GSM Chez Le diabétique De Type 1 Sous Traitement Insulinique Par Pompe Externe : Etude Prospective randomisée PumpNet.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Grenoble, France, 38043
- University Hospital, Department of Endocrinology
-
Toulouse, France, 31000
- University Hospital, Department of Endocrinology
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Type 1 diabetes mellitus
- Age ≥ 18
- HbA1c between 7.5 and 10%
- Treated with continuous subcutaneous insulin infusion for a minimum of 3 months
Exclusion Criteria:
- Unstabilized diabetic microangiopathy
- Ongoing pregnancy or planned pregnancy
- Unwilling to perform a minimum of 4 capillary blood tests per day
- Unable to use the GlucoNet device
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
|---|
|
Glycated hemoglobin HbA1c
|
|
monthly mean capillary blood glucose value
|
|
blood glucose variability index (MAGE Index and LBGI index)
|
|
quality of life score (DQOL score)
|
|
frequency of hypoglycemic episodes (<70 mg/dl)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Pierre Y Benhamou, MD, PhD, Universty Hospital, Grenoble, France
- Study Director: Helene Hanaire, MD, PhD, University Hospital, Toulouse, France
- Study Director: Serge Halimi, MD, University Hospital, Grenoble, France
- Study Director: Jean L Bosson, MD, PhD, CIC-INSERM
Study record dates
Study Major Dates
Study Start
Study Start
Study Completion
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- DCIC 03 01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.